Navigation Links
Supercomputing equipment to advance the frontiers of computational biology

Researchers at Rensselaer Polytechnic Institute will continue to advance the frontiers of computational science with the help of IBM's Blue Gene supercomputer. Awarded under IBM's Shared University Research (SUR) program, this Blue Gene will complement the $100 million partnership between Rensselaer, IBM, and New York state to create one of the world's most powerful university-based supercomputing centers.

The equipment will provide a resource for scientists to gain experience with the Blue Gene computing environment, while also supporting a project to develop new simulation technologies for understanding biological systems. The work will help researchers develop algorithms and software that run efficiently on Blue Gene technology, which is a key part of the new Computational Center for Nanotechnology Innovations (CCNI).

This $2.23 million gift of IBM equipment counts toward the $1.4 billion Renaissance at Rensselaer campaign.

"This award further advances the strong partnership between IBM and Rensselaer to develop a leading-edge, high-performance computational capability," said Rensselaer President Shirley Ann Jackson. "It will allow our faculty and students to take the lead in research that will enable key nanotechnology innovations in the fields of energy, biotechnology, arts, and medicine."

As biology becomes a more quantitative field, researchers need new simulation technologies to understand how proteins, DNA, and other biological systems behave at the molecular level, according to the Rensselaer research team. The new SUR award is designed to help develop simulations for prototyping medical devices in "virtual patients," with potential applications in targeted drug delivery systems such as drug eluting stents, transdermal patches, and inhalers.

To be successful, these simulations must run efficiently and effectively on the latest generation of high-performance computing equipment. The project will help researcher
'"/>

Source:Rensselaer Polytechnic Institute


Page: 1 2

Related biology news :

1. Aptamer-based Biosensor screens Air Force personnel and equipment
2. A step toward the $1,000 personal genome using readily available lab equipment
3. Research advances quest for HIV-1 vaccine
4. Inexpensive, mass-produced genes core of synthetic biology advances at UH
5. Study of genomic DNA leads to new advances in cancer diagnostics
6. Molecular models advance the fight against malaria
7. Researchers test new therapy for advanced melanoma
8. Agilent Technologies introduces advanced zebrafish, mouse microarrays for stem cell and developmental biology research
9. Major advance made on DNA structure
10. Wild grasses and man-made wheats advance research capabilities
11. Gene therapy advance treats hemophilia in mouse models

Post Your Comments:
(Date:12/3/2009)...e measured CO2 levels for the past three years in ... inhabited rural area near Valladolid. The results... Peninsula, show that the levels rose "significant...physicists and meteorologists have been trying to ...w these have evolved in the troposphere over vario...
(Date:12/3/2009)... Antarctic snowmelt that occurred during the 2008-...ong positive phases for two main climate drivers, ...hern Hemisphere Annular Mode), according to Dr. Ma...heric Sciences at The City College of New York. ... faculty at the CUNY Graduate Center, added that A...
(Date:12/2/2009)... results strengthen the evidence that people who s... increased risk for developing colorectal cancer, ..."This provides one more reason not to smoke, or to...hael J. Thun, M.D., M.S., vice president emeritus,...rican Cancer Society. "Colorectal cancer should be...
Breaking Biology News(10 mins):CO2 levels rising in troposphere over rural areas 2CCNY professor foresees rising Antarctic snowmelt 2Cigarette smoking increases colorectal cancer risk 2Vasogen and IntelliPharmaCeutics to Combine to Create Publicly traded Specialty Pharmaceutical Company 13587 1Vasogen and IntelliPharmaCeutics to Combine to Create Publicly traded Specialty Pharmaceutical Company 13587 2Vasogen and IntelliPharmaCeutics to Combine to Create Publicly traded Specialty Pharmaceutical Company 13587 3Vasogen and IntelliPharmaCeutics to Combine to Create Publicly traded Specialty Pharmaceutical Company 13587 4Vasogen and IntelliPharmaCeutics to Combine to Create Publicly traded Specialty Pharmaceutical Company 13587 5Vasogen and IntelliPharmaCeutics to Combine to Create Publicly traded Specialty Pharmaceutical Company 13587 6Vasogen and IntelliPharmaCeutics to Combine to Create Publicly traded Specialty Pharmaceutical Company 13587 7Vasogen and IntelliPharmaCeutics to Combine to Create Publicly traded Specialty Pharmaceutical Company 13587 8Vasogen and IntelliPharmaCeutics to Combine to Create Publicly traded Specialty Pharmaceutical Company 13587 9Professor Nancy Ip Joins aTyr Pharmas Scientific Advisory Board 13585 1Professor Nancy Ip Joins aTyr Pharmas Scientific Advisory Board 13585 2BioLife Solutions and STEMCELL Technologies Announce Worldwide Distribution Agreement 13583 1BioLife Solutions and STEMCELL Technologies Announce Worldwide Distribution Agreement 13583 2BioLife Solutions and STEMCELL Technologies Announce Worldwide Distribution Agreement 13583 3
..., ISRAEL, April 28, 2009 ZenithSolar, an Israeli ...near Tel Aviv on April 26, based on concentrated p... Faiman of Ben-Gurion University of the Negev (BG...rman of the Department of Solar Energy and Environ... for Desert Research, believes the new system will...
...s will gather soon for the 61st Annual Meeting of ...ty of America, being held 11-13 May 2009 in Orem, ... meeting in their new library building on the UVU ... The technical program, presented by academic and ...e students, will highlight cutting-edge scientific...
...ll. Researchers at the University of Illinois hav...the targeted delivery of one or more molecules int... addition to ferrying tiny amounts of cargo, the n...robe and as an optical biosensor., "Nanoneedle-ba...iological processes and biophysical properties at ...
Other Biology News:Ben-Gurion University research and technology used in new solar energy farm 2Geoscientists meet to discuss Rocky Mountain geology 2Nanoneedle is small in size, but huge in applications 2
(Date:12/2/2009)... , CALGARY, Dec. 2 /PRNewswire-FirstCal..."Company") (TSX:ONC; NASDAQ: ONCY ) announced toda... unit offering, the underwriters have exercised in... additional 637,500 units. Each unit is comprised ...hase warrant, and was sold at a price of US$3.00 p...
(Date:12/2/2009)... , SINGAPORE, Dec. 2 S*B...ts novel oral JAK2 inhibitor, SB1518, at The Ameri...Exposition in New Orleans. ,, Data will be pres...e-escalation trial of SB1518 detailing its safety,...(PK/PD) profile in dose levels ranging from 100 to...
(Date:12/2/2009)... The Scientist, a leading scie... Photometrics’ Evolve “Intelligent&rdq...o;s “Top 10 Innovations of 2009. , ...volve ™ EMCCD camera from Photometrics &re...e CCD and EMCCD cameras for the life sciences, was...
(Date:12/1/2009)... , NEW YORK, Dec. 1 Repo...report is available in its catalogue: ,, Indus...p://www.reportlinker.com/p0164431/Industrial-Enzym... Enzymes market is an oligopoly with few strong pl...he market activities. Keen competition and commodi...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 2The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 3Reportlinker Adds Industrial Enzymes - A Global Market Report 2Reportlinker Adds Industrial Enzymes - A Global Market Report 3Reportlinker Adds Industrial Enzymes - A Global Market Report 4Reportlinker Adds Industrial Enzymes - A Global Market Report 5Reportlinker Adds Industrial Enzymes - A Global Market Report 6Reportlinker Adds Industrial Enzymes - A Global Market Report 7Reportlinker Adds Industrial Enzymes - A Global Market Report 8Reportlinker Adds Industrial Enzymes - A Global Market Report 9Reportlinker Adds Industrial Enzymes - A Global Market Report 10
...O, SOUTH SAN FRANCISCO, Calif., May 28 Exelixis,...alyst briefing in,conjunction with the 44th Annual...ogy (ASCO) from 6:00 p.m. to 8:00 p.m. CT on Monda...ngos, PhD, President and Chief Executive Officer ...h and Development -- Gisela M. Schwab, MD, Execut...
...website initially focusing on proteins and their r...technology underlying the site has been developed ...escribed in BioMed Centrals open access journal Ge...ommunity annotation on a huge scale. , The artic...l Center in Rotterdam, and the Leiden University M...
...tion, carbon nanotubes which are about 100,000 ti...unique and very useful properties have become the...anosized electronic and mechanical devices. But it...ell as their tendency to clump together, that make...es. , Dr. Ernesto Joselevich, together with Ph.D....
Other Biology Technology:REMINDER: Exelixis Will Webcast Its June 2 Investor and Analyst Briefing at ASCO 2REMINDER: Exelixis Will Webcast Its June 2 Investor and Analyst Briefing at ASCO 3REMINDER: Exelixis Will Webcast Its June 2 Investor and Analyst Briefing at ASCO 4Large-scale community protein annotation -- WikiProteins 2Weizmann Institute scientists create new nanotube structures 2
...ay studies, protein-protein interaction studies, a...uilt on the flexible and powerful Paraflo microflu... are available as part of our comprehensive Custom...t Probe content is completely customer specified....
...lick image analysis software for microarray includ...on for high quality and high throughput array syst...hs robust algorithms, actual spot boundary, flexib...ection and dust removal, enhancing the accuracy of...
a-Hyb Hybridization Station from Miltenyi Biotec
...ocyte Progenitors, Rabbit, and media. Cryo-preserv... at passage 25 (approx), supplied with kit (500 mL...d as a long-term culture, and is guaranteed to pro...rom the date supplied, when used with the recommen...
Biology Products: